115 related articles for article (PubMed ID: 9724093)
21. Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine.
Martin KJ; Vassallo CD; Teicher BA; Kaddurah-Daouk R
Anticancer Drugs; 1995 Jun; 6(3):419-26. PubMed ID: 7670140
[TBL] [Abstract][Full Text] [Related]
22. Cyclocreatine accumulation leads to cellular swelling in C6 glioma multicellular spheroids: diffusion and one-dimensional chemical shift nuclear magnetic resonance microscopy.
Schiffenbauer YS; Tempel C; Abramovitch R; Meir G; Neeman M
Cancer Res; 1995 Jan; 55(1):153-8. PubMed ID: 7805026
[TBL] [Abstract][Full Text] [Related]
23. Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy.
Schiffenbauer YS; Meir G; Cohn M; Neeman M
Am J Physiol; 1996 Jan; 270(1 Pt 1):C160-9. PubMed ID: 8772441
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle studies of cyclocreatine, a new anticancer agent.
Martin KJ; Winslow ER; Kaddurah-Daouk R
Cancer Res; 1994 Oct; 54(19):5160-5. PubMed ID: 7923134
[TBL] [Abstract][Full Text] [Related]
25. Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency.
Do MT; Cavagnaro J; Butt M; Terse PS; McKew JC
Regul Toxicol Pharmacol; 2021 Jul; 123():104939. PubMed ID: 33961952
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism.
Ara G; Gravelin LM; Kaddurah-Daouk R; Teicher BA
In Vivo; 1998; 12(2):223-31. PubMed ID: 9627806
[TBL] [Abstract][Full Text] [Related]
27. Creatine and cyclocreatine attenuate MPTP neurotoxicity.
Matthews RT; Ferrante RJ; Klivenyi P; Yang L; Klein AM; Mueller G; Kaddurah-Daouk R; Beal MF
Exp Neurol; 1999 May; 157(1):142-9. PubMed ID: 10222117
[TBL] [Abstract][Full Text] [Related]
28. Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Patel R; Ford CA; Rodgers L; Rushworth LK; Fleming J; Mui E; Zhang T; Watson D; Lynch V; Mackay G; Sumpton D; Sansom OJ; Vande Voorde J; Leung HY
Cancer Res; 2022 Jul; 82(14):2565-2575. PubMed ID: 35675421
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells.
Kohn EC; Francis EA; Liotta LA; Schiffmann E
Int J Cancer; 1990 Aug; 46(2):287-92. PubMed ID: 2116998
[TBL] [Abstract][Full Text] [Related]
30. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
[TBL] [Abstract][Full Text] [Related]
31. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase.
Cui MH; Jayalakshmi K; Liu L; Guha C; Branch CA
NMR Biomed; 2015 Dec; 28(12):1634-44. PubMed ID: 26451872
[TBL] [Abstract][Full Text] [Related]
32. Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices.
Enrico A; Patrizia G; Luisa P; Alessandro P; Gianluigi L; Carlo G; Maurizio B
J Integr Neurosci; 2013 Jun; 12(2):285-97. PubMed ID: 23869866
[TBL] [Abstract][Full Text] [Related]
33. Relationship of cellular energy parameters to cytotoxicity for AG-17, lonidamine and cyclocreatine in four human tumor cell lines.
Ara G; Teicher B
Int J Oncol; 1996 May; 8(5):865-73. PubMed ID: 21544439
[TBL] [Abstract][Full Text] [Related]
34. Relative abilities of phosphagens with different thermodynamic or kinetic properties to help sustain ATP and total adenylate pools in heart during ischemia.
Turner DM; Walker JB
Arch Biochem Biophys; 1985 May; 238(2):642-51. PubMed ID: 3994395
[TBL] [Abstract][Full Text] [Related]
35. Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin 1.
Guo N; Zabrenetzky VS; Chandrasekaran L; Sipes JM; Lawler J; Krutzsch HC; Roberts DD
Cancer Res; 1998 Jul; 58(14):3154-62. PubMed ID: 9679984
[TBL] [Abstract][Full Text] [Related]
36. Cyclocreatine inhibits neutrophil accumulation in the myocardium of a canine model of coronary artery occlusion and reperfusion.
Elgebaly SA; Allam ME; Houser S; Hashmi F; Forouhar F; Miano D
J Pharmacol Exp Ther; 1993 Sep; 266(3):1670-7. PubMed ID: 8371165
[TBL] [Abstract][Full Text] [Related]
37. Isoleucine 69 and valine 325 form a specificity pocket in human muscle creatine kinase.
Novak WR; Wang PF; McLeish MJ; Kenyon GL; Babbitt PC
Biochemistry; 2004 Nov; 43(43):13766-74. PubMed ID: 15504039
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of creatine against inhibition by methylglyoxal of mitochondrial respiration of cardiac cells.
Roy SS; Biswas S; Ray M; Ray S
Biochem J; 2003 Jun; 372(Pt 2):661-9. PubMed ID: 12605598
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
40. Cytoskeletal agents inhibit motility and adherence of human tumor cells.
Stracke ML; Soroush M; Liotta LA; Schiffmann E
Kidney Int; 1993 Jan; 43(1):151-7. PubMed ID: 8094471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
